Knowledge Center
Article / Jun 08, 2009
The View From New Jersey
Source:
C&EN, 8 June, 2009
In the spring of 2003, ËÄÉ«AV opened a small-scale production facility in East Windsor, N.J. As its name implies, the $20 million Technology Transfer Center was intended as a place to develop customers' molecules before moving them to headquarters in Loures, Portugal, for scale-up. Given ËÄÉ«AV's target market of small to midsized drug companies, TTC was meant to boost business with U.S. biotech firms.
Related links
Also in the Knowledge Center
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop
Read more
Scientific Article
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights
Read more
Scientific Article
Scientific Article